During the last session, Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares were 0.33 million, with the beta value of the company hitting 0.82. At the end of the trading day, the stock’s price was $1.56, reflecting an intraday loss of -4.88% or -$0.08. The 52-week high for the WINT share is $737.43, that puts it down -47171.15 from that peak though still a striking 7.05% gain since the share price plummeted to a 52-week low of $1.45. The company’s market capitalization is $1.09M, and the average intraday trading volume over the past 10 days was 15.24 million shares, and the average trade volume was 2.87 million shares over the past three months.
Windtree Therapeutics Inc (WINT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. WINT has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -39.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Windtree Therapeutics Inc (WINT) registered a -4.88% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.88% in intraday trading to $1.56, hitting a weekly high. The stock’s 5-day price performance is 5.41%, and it has moved by -54.65% in 30 days. Based on these gigs, the overall price performance for the year is -99.51%. The short interest in Windtree Therapeutics Inc (NASDAQ:WINT) is 49264.0 shares and it means that shorts have 0.08 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 66.05%. While earnings are projected to return 96.33% in 2025.
WINT Dividends
Windtree Therapeutics Inc is due to release its next quarterly earnings on 2024-Nov-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Windtree Therapeutics Inc insiders own 0.07% of total outstanding shares while institutional holders control 1.77%, with the float percentage being 1.77%.
Also, the Mutual Funds coming in first place with the largest holdings of Windtree Therapeutics Inc (WINT) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Jan 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 1.17 shares. This amounts to just over 0.08 percent of the company’s overall shares, with a $1826.0 market value. The same data shows that the other fund manager holds slightly less at 46.0, or about 0.00% of the stock, which is worth about $71.0.
